News & Events

Date	Title	Format
Apr 01, 2026	Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement	PDF Version
Feb 17, 2026	Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board	PDF Version
Jan 05, 2026	Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression	PDF Version